Neuphoria Therapeutics Inc. (NEUP) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-07-24 | 8-K | Material Agreement, Change in Control, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-05-26 | 8-K | Other Events | SEC |
| 2026-01-08 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2025-12-18 | 8-K | Listing Notice | SEC |
| 2025-12-17 | 8-K | Shareholder Vote Results | SEC |
| 2025-10-27 | 8-K | Material Agreement, Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-16 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-07-18 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-05-20 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-14 | 8-K | Other Events | SEC |
| 2024-12-23 | 8-K | Material Agreement, Listing Notice, Unregistered Sales, Item 3.03, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-16 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-12 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-11-21 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-11-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-10 | 8-K | Officer / Director Changes | SEC |
| 2024-10-02 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-07-16 | 8-K | Listing Notice | SEC |
| 2024-06-03 | 6-K | — | SEC |
| 2024-03-15 | 6-K | — | SEC |
| 2024-01-04 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.